Amidophenoxyindazoles useful as inhibitors of c-Met

Details for Australian Patent Application No. 2009274256 (hide)

Owner Eli Lilly and Company

Inventors Li, Tiechao; Pobanz, Mark Andrew; Shih, Chuan; Wu, Zhipei; Yang, Wei Jennifer; Zhong, Boyu

Agent Spruson & Ferguson

Pub. Number AU-A-2009274256

PCT Pub. Number WO2010/011538

Priority 61/108,659 27.10.08 US; 61/085,082 31.07.08 US; 61/083,294 24.07.08 US

Filing date 15 July 2009

Wipo publication date 28 January 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/011538 Priority application(s): WO2010/011538

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274258-Fuel efficiency improvement for locomotive consists

2009274255-Inhibitors of the plasmodial surface anion channel as antimalarials